Synapse

← Charles M. Perou

Papers by Charles M. Perou

Page 8 · newest first

  1. Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657Journal of Clinical Oncology · 2012
  2. Dietary Energy Balance Modulates Epithelial-to-Mesenchymal Transition and Tumor Progression in Murine Claudin-Low and Basal-like Mammary Tumor ModelsCancer Prevention Research · 2012
  3. Differential Pathogenesis of Lung Adenocarcinoma Subtypes Involving Sequence Mutations, Copy Number, Chromosomal Instability, and MethylationSHILAP Revista de lepidopterología · 2012
  4. Oncogenic PI3K Mutations Lead to NF-κB–Dependent Cytokine Expression following Growth Factor DeprivationCancer Research · 2012
  5. Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifenAnnals of Oncology · 2012
  6. Integrated Analyses of microRNAs Demonstrate Their Widespread Influence on Gene Expression in High-Grade Serous Ovarian CarcinomaPLoS ONE · 2012
  7. Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized TrialClinical Cancer Research · 2012
  8. Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer TherapyJNCI Journal of the National Cancer Institute · 2012
  9. Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)Breast Cancer Research and Treatment · 2011
  10. The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epitheliumProceedings of the National Academy of Sciences · 2011
  11. Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survivalBreast Cancer Research and Treatment · 2011
  12. Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low featuresBMC Medical Genomics · 2011
  13. Maintenance of hormone responsiveness in luminal breast cancers by suppression of NotchProceedings of the National Academy of Sciences · 2011
  14. Defining the cellular precursors to human breast cancerProceedings of the National Academy of Sciences · 2011
  15. Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signalingProceedings of the National Academy of Sciences · 2011
  16. Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapseBreast Cancer Research and Treatment · 2011
  17. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cellsProceedings of the National Academy of Sciences · 2011
  18. RB1 and p53 at the crossroad of EMT and triple-negative breast cancerCell Cycle · 2011
  19. Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signaturesBMC Medical Genomics · 2011
  20. Molecular Stratification of Triple-Negative Breast CancersThe Oncologist · 2011
  21. Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer StudyClinical Cancer Research · 2010
  22. Interactions with Fibroblasts Are Distinct in Basal-Like and Luminal Breast CancersMolecular Cancer Research · 2010
  23. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastasesCancer · 2010
  24. Deconstructing the molecular portraits of breast cancerMolecular Oncology · 2010
  25. Systems Biology and Genomics of Breast CancerCold Spring Harbor Perspectives in Biology · 2010
  26. Molecular Stratification of Triple-Negative Breast CancersThe Oncologist · 2010
  27. Potential Tumor Suppressor Role for the c-Myb Oncogene in Luminal Breast CancerPLoS ONE · 2010
  28. A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast CancerClinical Cancer Research · 2010
  29. Allele-specific copy number analysis of tumorsProceedings of the National Academy of Sciences · 2010
  30. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancerBreast Cancer Research · 2010
  31. MapSplice: Accurate mapping of RNA-seq reads for splice junction discoveryNucleic Acids Research · 2010
  32. Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 statusJournal of Clinical Investigation · 2010
  33. Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell TypesClinical Cancer Research · 2010
  34. A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal AdenocarcinomaSHILAP Revista de lepidopterología · 2010
  35. Mitochondrial HEP27 Is a c-Myb Target Gene That Inhibits Mdm2 and Stabilizes p53Molecular and Cellular Biology · 2010
  36. Fibroblast Growth Factor Receptor Signaling Dramatically Accelerates Tumorigenesis and Enhances Oncoprotein Translation in the Mouse Mammary Tumor Virus–Wnt-1 Mouse Model of Breast CancerCancer Research · 2010
  37. SWISS MADE: Standardized WithIn Class Sum of Squares to Evaluate Methodologies and Dataset ElementsPLoS ONE · 2010
  38. Relationship Between Plasma Estradiol Levels and Estrogen-Responsive Gene Expression in Estrogen Receptor–Positive Breast Cancer in Postmenopausal WomenJournal of Clinical Oncology · 2010
  39. Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF12010
  40. Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell · 2010
  41. Response: Re: Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast CancerJNCI Journal of the National Cancer Institute · 2009
  42. Activation of Host Wound Responses in Breast Cancer MicroenvironmentClinical Cancer Research · 2009
  43. Finding large average submatrices in high dimensional dataThe Annals of Applied Statistics · 2009
  44. Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast CancerJournal of Clinical Oncology · 2009
  45. A Core MYC Gene Expression Signature Is Prominent in Basal-Like Breast Cancer but Only Partially Overlaps the Core Serum ResponsePLoS ONE · 2009
  46. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresProceedings of the National Academy of Sciences · 2009
  47. An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancerBreast Cancer Research · 2009
  48. Integrated study of copy number states and genotype calls using high-density SNP arraysNucleic Acids Research · 2009
  49. A Novel Lung Metastasis Signature Links Wnt Signaling with Cancer Cell Self-Renewal and Epithelial-Mesenchymal Transition in Basal-like Breast CancerCancer Research · 2009
  50. Secreted Frizzle-Related Protein 2 Stimulates Angiogenesis via a Calcineurin/NFAT Signaling PathwayCancer Research · 2009